key: cord-0780080-jcjaj884 authors: Pitak-Arnnop, Poramate; Auychai, Prim; Neff, Andreas title: Dental aerosols should not be ignored during the COVID-19 pandemic until proven otherwise. date: 2022-05-08 journal: J Evid Based Dent Pract DOI: 10.1016/j.jebdp.2022.101745 sha: c6ff8f64cd833f78b4af3b9842a7f0da51c17a28 doc_id: 780080 cord_uid: jcjaj884 nan To answer the clinical research question: "Are aerosol-generating dental procedures (AGDPs) linked to significant aerosol distribution, and subsequent SARS-CoV-2 transmission?" The authors reported that no external funding sources directly supported this study. Level 3: Extrapolations from bench research or disease-oriented evidence Grade C: Recommendations based on bench or disease-oriented evidence This was an experimental research in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for human observational investigations. Meethil et al. enrolled a sample of 28 dental patients and 5 dental personnel between 4 May and 10 July 2020 at the College of Dentistry of the Ohio State University. Inclusion criteria were not mentioned. The subjects for dental treatments were excluded, if they were < 18 years, currently pregnant, previously treated with antibiotics, or self-reported about HIV infection or COVID-19, or COVID-19-like symptoms since January 2020 (i.e. all symptomatic cases were excluded). The investigators calculated the sample size based on in vitro and clinical non-SARS-CoV-2related studies. The aerosol-generating dental procedures (AGDPs) were performed under high-power suctioning by 5 dentists and dental assistants wearing N95 masks in 2 enclosed operatories measuring 10.5×10×12 ft., with 6exchange/min ventilation. All except 5 scaling patients (82.1%) rinsed 1% H 2 O 2 30 ml for 1 min before treatment began. The predictor variables included 1) timing in relation to dental treatments (before vs. after [30 min after The main outcome variable was the frequency of identifiable microorganisms, which was measured by microbiologic-genetic techniques for microbial DNA sequences, and an RNA extraction-free dualplexed reverse transcriptase quantitative polymerase chain reaction (qRT-PCR) for SARS-CoV-2 detection (SalivaDirect ™ version 5). There were statistical significances between postoperative salivary and aerosol microbiota, regardless of type of AGDPs and location of sample collecting (P < 0.001, Dunn method for joint ranking of Bray-Curtis dissimilarity distances). Vulcaniibacteria was identifiable in 70% of microbial abundance. The aerosolised microbial abundance was 8.3 to 10 times more than saliva bacteria, which were found in 8 (or 28.6%) patients [5 of those did not rinse H 2 O 2 ]. However, the source of 0%-90% of the microbiota (mean, 20%) was unknown. The patient's chest was the most frequent site of germ deposition (P < 0.05, chi-square test), despite in 8 patients only. On the contrary, SARS-CoV-2 was detected in saliva of 19 participants (viral load, 27-912 copies/ml). No aerosol with SARS-CoV-2 in any location was found. The investigators concluded that with appropriate infection control measures, i.e. preoperative mouth rinses and intraoral high-volume suction, dental treatment in asymptomatic patients does not decrease the risk of SARS-CoV-2 transmission. Standard infection control is sufficiently to protect personnel and patients from exposure to potential pathogens. The microbial aerosol is stable colloidal system of microorganisms floating in air in the state of a single cell suspension or fused with dry solid or liquid particles. Viral aerosols have small size and have Brownian motion, causing a long-time suspension, far-distance transmission and access to the lower respiratory tract. 1 Dental environments are in closed spaces, and many AGDPs intensively generate aerosols compared to normallife activities. Since the risk of SARS-CoV-2 infection is cumulative, directly proportional to the duration of exposure (apart from the viral density), repeated inhalation of several particles, although containing smaller viral doses) can inevitably lead to an infection. 2 Theoretically, aerosol particles are dry very quickly: milliseconds to seconds. Enveloped RNA viruses, e.g. influenza and coronaviruses, may be unstable in dried aerosol nuclei for extended periods, limiting the viral ability to transmit. 2 The SARS-CoV-2, conversely, remains viable in aerosols for 3 hours with a reduction in infectious titre from 10 3.5 to 10 2.7 mean (or 50%) tissue culture infectious dose (TCID 50 )/l air at 21-23°C and 65% relative humidity. 1 A Florida study demonstrated "viable" SARS-CoV-2 isolated from air samples collected 2 to 4.8 m (6.6 to 15.7 ft.) away from the patients in the absence of AGDPs. For aerosol-based transmission, measures such as physical distancing by 6 ft. would not be helpful in an indoor setting, provide a false-sense of security, and lead to exposures and outbreaks. 3 Furthermore, AGDPs increase humidity in dental environments. Airflow dispersed by human activities, ventilation and high-power suctioning could also cause resuspension of the aerosols that are already deposited on the surfaces. 1 Recently, we found SARS-CoV-2 distribution in an operating theatre up to 3 m during midfacial fracture repair under general anaesthesia. 4 Hence, SARS-CoV-2 transmission from asymptomatic or mildly symptomatic patients should not be underestimated, especially in areas with incidence of ≥ 150 new cases per 100,000 population per week. 5 Meethil et al. enrolled a cohort of 28 dental patients with unknown inclusion criteria and appeared unrepresentative to the real-world statistics, i.e. selection bias is possible. Moreover, they detected the viral load of 27-912 copies/ml, although SalivaDirect ™ can actually detect viral loads as low as 6,000-12,000 copies/ml. 6 Compared to reverse transcription polymerase chain reaction (qRT-PCR), SalivaDirect ™ had false-positive rates of 0.03%-0.05% (n = 3,760) 6 , suggesting the missing of ≥ two COVID-19 patients in the Meethil et al.'s study. A meta-analysis showed that salivary SARS-CoV-2 testing may be less sensitive (up to 16.6 times) than qRT-PCR. 7 SalivaDirect ™ provides significantly lower detect rates: 61.9% to 96.4%. 8 This could be a result of accidental collection of sputum and/or remnants from food/drinks, or even brushing teeth prior to saliva collection, which can interfere sample processing or inhibit PCR. 6, 8 The discrepancies between salivary testing vs. standard RT-PCR, amid cheaper, tend to decrease in asymptomatic or mildly symptomatic patients, and can be used as "only" for screening in communities. 7, 8 Given sample size calculation for differences in measurements among three unpaired groups (ultrasonic scaling vs. drilling vs. implant placement) at α = 0.05 and power of 80%, the overall effect size (calculated from the salivary viral load: 175.73 ± 235.08 vs. 44.43 ± 13.74 vs. 29.85 ± 46.49, respectively) will be 7.21, and ≥ 29 subjects are required in each study arm (i.e. total sample size ≥ 87). The low sample size in the Meethil et al.'s study may explain the insignificance among AGDP types (i.e. the results could not escape from the β-error). 9 Gargling with 1%-3% H 2 O 2 in the mouth and throat for 1 min 1-3 times a day (for up to 6 months) has proven effective against SARS-CoV-2. The antiseptic action via oxidising and mechanical removal is intensified by the induction of the innate antiviral inflammatory response by overexpression of Toll-like receptor 3 (TLR3). 10 In conclusion, several factors in the Meethil et al.'s study, e.g. high probability of selection bias and non-representative samples, inappropriate use of salivary SARS-CoV-2 testing as standard in the research setting, improper analysis of dental aerosols, and the high risk of β-errors (i.e. false-negative errors) due to the low sample size, could altogether compromise the scientific integrity. This paper's findings may cause great confusion in dental communities during the COVID-19 pandemic, and thereby, should be interpreted cautiously. We refer interested readers to up-to-date dental managements during the COVID-19 pandemic by Hegde et al. 11 , and our meta-narrative review of oral-maxillofacial manifestations in COVID-19 patients. 12 Aerosol transmission of coronavirus and influenza virus of animal origin SARS-CoV-2 aerosol and droplets: An overview. Virusdisease Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients Inanimate surface contamination of SARS-CoV-2 during midfacial fracture repair in asymptomatic COVID-19 patients SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity The sensitivity and costs of testing for SARS-CoV-2 infection with saliva versus nasopharyngeal swabs: A systematic review and meta-analysis Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: A systematic review and meta-analysis Evidence-based oral and maxillofacial surgery: Some pitfalls and limitations Might hydrogen peroxide reduce the hospitalization rate and complications of SARS-CoV-2 infection? Dental practice management during COVID-19 times-Now and beyond A German AWMF's S2e/realist synthesis and meta-narrative snapshot of craniomaxillofacial manifestations in COVID-19 patients: Rapid living update on 1 The authors (reviewers) indicated neither funding nor conflicts of interest in relation to this work.